Compare
Bruker vs Medtronic (BRKR vs MDT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Bruker (BRKR) returned +52.5% and Medtronic (MDT) +12.6%; so far this year the figures are +30.1% and +6.0%.
Medtronic is the larger company by market value, about 13.9 times the size of Bruker.
Revenue grew +2.2% at BRKR and +9.8% at MDT over the last year.
BRKR yields 0.33%. MDT yields 2.81%.
Data as of the latest close. Not investment advice.
Relative performance
| BRKR | MDT | |
|---|---|---|
| Price | $61.31 | $101.80 |
| 1-day | +5.60% | -2.90% |
| YTD | +30.14% | +5.98% |
| 1 year | +52.51% | +12.61% |
| 3 years | +7.54% | +43.68% |
| Market cap | $9.3B | $130.2B |
| P/E | — | 25.0 |
| P/S | 2.66 | 3.47 |
| P/B | 4.05 | 2.59 |
| Revenue growth | +2.20% | +9.80% |
| EPS growth | — | +12.10% |
| Gross margin % | 47.7 | 65.0 |
| Net margin % | -3.5 | 13.9 |
| ROE % | -5.4 | 10.4 |
| Debt / equity | 0.74 | 0.56 |
| FCF yield % | 2.6 | 4.7 |
| Dividend yield % | 0.33 | 2.81 |
| Beta | 1.65 | 0.14 |
| RSI (14) | 53.9 | 63.8 |
| Technical rating |